Melguizo Alonso, Consolación Author
Electrospun nanofibers: Recent applications in drug delivery and cancer therapy
- Contreras-Cáceres R.
- Cabeza L.
- Perazzoli G.
- Díaz A.
- López-Romero J.
- Melguizo C.
- Prados J.
Nanomaterials - 1/4/2019
- SJR Quartile: Q1
- JCR Impact Factor: 4.324 (2019)
- CiteScore: 4.21 (2018)
- SJR: 0.896 (2018
- SNIP: 1.112 (2018
- JCR 5-year Impact Factor: 4.514
- JCR Categories: NANOSCIENCE & NANOTECHNOLOGY
- SJR Categories: Chemical Engineering (miscellaneous) (Q1); Materials Science (miscellaneous) (Q1)
- Scopus
- ORCID
- Web of Science
An updated review of adipose derived-mesenchymal stem cells and their applications in musculoskeletal disorders
- Rivera-Izquierdo M.
- Cabeza L.
- Láinez-Ramos-Bossini A.
- Quesada R.
- Perazzoli G.
- Alvarez P.
- Prados J.
- Melguizo C.
EXPERT OPINION ON BIOLOGICAL THERAPY - 4/3/2019
- SJR Quartile: Q1
- JCR Impact Factor: 3.224 (2019)
- CiteScore: 6.4 (2020)
- SJR: 0.917 (2019
- SNIP: 0.76 (2019
- JCR 5-year Impact Factor: 3.109
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q2)
- Scopus
- ORCID
- Web of Science
A novel nanoformulation of PLGA with high non-ionic surfactant content improves in vitro and in vivo PTX activity against lung cancer
- Jiménez-López J.
- El-Hammadi M.
- Ortiz R.
- Cayero-Otero M.
- Cabeza L.
- Perazzoli G.
- Martin-Banderas L.
- Baeyens J.
- Prados J.
- Melguizo C.
PHARMACOLOGICAL RESEARCH - 1/3/2019
- SJR Quartile: Q1
- JCR Impact Factor: 5.893 (2019)
- CiteScore: 10.1 (2020)
- SJR: 1.609 (2019
- SNIP: 1.483 (2019
- JCR 5-year Impact Factor: 5.631
- JCR Categories: PHARMACOLOGY & PHARMACY
- SJR Categories: Pharmacology (Q1)
- Scopus
- ORCID
- Web of Science
Double origin of the extensor hallucis longus muscle: a case report
- Egea J.
- Cabeza L.
- Ortiz R.
- Rama A.
- Melguizo C.
- Prados J.
SURGICAL AND RADIOLOGIC ANATOMY - 1/12/2019
- SJR Quartile: Q2
- JCR Impact Factor: 1.092 (2019)
- CiteScore: 1.9 (2020)
- SJR: 0.487 (2019
- SNIP: 1.069 (2019
- JCR 5-year Impact Factor: 1.229
- JCR Categories: SURGERY
- SJR Categories: Anatomy (Q2); Surgery (Q2); Pathology and Forensic Medicine (Q3); Radiology, Nuclear Medicine and Imaging (Q3)
- Scopus
- ORCID
- Web of Science
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
- Martín-Blázquez A.
- Díaz C.
- González-Flores E.
- Franco-Rivas D.
- Jiménez-Luna C.
- Melguizo C.
- Prados J.
- Genilloud O.
- Vicente F.
- Caba O.
- Pérez del Palacio J.
Scientific Reports - 1/12/2019
- SJR Quartile: Q1
- JCR Impact Factor: 3.998 (2019)
- JCR 5-year Impact Factor: 4.576
- JCR Categories: MULTIDISCIPLINARY SCIENCES
- SJR Categories: Multidisciplinary (Q1)
The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview
- Quiñonero F.
- Mesas C.
- Doello K.
- Cabeza L.
- Perazzoli G.
- Jimenez-Luna C.
- Rama A.
- Melguizo C.
- Prados J.
Cancer Biology and Medicine - 1/11/2019
10.20892/j.issn.2095-3941.2019.0252
- SJR Quartile: Q1
- JCR Impact Factor: 5.432 (2019)
- CiteScore: 6.8 (2020)
- SJR: 1.927 (2019
- SNIP: 1.657 (2019
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
- SJR Categories: Cancer Research (Q1); Oncology (Q1)
- Scopus
- ORCID
- Web of Science
The expression of MMR, CD133 and the presence of p53 wt predict the response to cabazitaxel in malignant neural tumours cell lines
- Doello, K.
- Mesas, C.
- Perazzoli, G.
- Garcia-Collado, C.
- Gandara, M. J.
- Garcia-Fumero, R.
- Fuel, M.
- Luque, R.
- Ortiz, R.
- Melguizo, C.
- Prados, J. C.
ANNALS OF ONCOLOGY - 10/2019
Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer
- Rosa Rama A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2019
- SJR Quartile: Q2
- JCR Impact Factor: 4.534 (2019)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 3.997
- JCR Categories: BIOTECHNOLOGY & APPLIED MICROBIOLOGY
- SJR Categories: Molecular Medicine (Q2); Cancer Research (Q3); Molecular Biology (Q3)
- Scopus
- ORCID
- Web of Science
Nanoformulations for glioblastoma multiforme: A new hope for treatment
- Ortiz R.
- Cabeza L.
- Perazzoli G.
- Jimenez-Lopez J.
- García-Pinel B.
- Melguizo C.
- Prados J.
Future Medicinal Chemistry - 1/1/2019
- SJR Quartile: Q2
- JCR Impact Factor: 3.607 (2019)
- CiteScore: 5.2 (2020)
- SJR: 0.739 (2019
- SNIP: 0.802 (2019
- JCR 5-year Impact Factor: 4.065
- JCR Categories: CHEMISTRY, MEDICINAL
- SJR Categories: Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)
- Scopus
- ORCID
- Web of Science
DNA methylation patterns as molecular biomarkers: An overview in colorectal cancer
- González-Flores E.
- Hernández R.
- Álvarez P.
- Cabeza L.
- Perazzoli G.
- Zafra I.
- Melguizo C.
- Prados J.
- Rama A.
European Journal of Anatomy - 1/7/2018
- SJR Quartile: Q3
- CiteScore: 0.5 (2020)
- SJR: 0.174 (2018
- SNIP: 0.289 (2018
- SJR Categories: Anatomy (Q3)
- Dialnet
- Scopus
- ORCID
- Web of Science
Role of cancer stem cells of breast, colon, and melanoma tumors in the response to antitumor therapy
- Marchal J.
- García M.
- Boulaiz H.
- Perán M.
- Álvarez P.
- Prados J.
- Melguizo C.
- Aránega A.
Stem Cells and Cancer Stem Cells, Volume 3: Stem Cells and Cancer Stem Cells, Therapeutic Applications in Disease and Injury: Volume 3 - 1/1/2012
- Scopus
- ORCID
The story of a doctoral thesis: GEF, a new gene with applications in anti-tumor gene therapy
- Boulaiz, H
- Prados, J
- Melguizo, C
- Marchal, JA
- Carrillo, E
- Velez, C
- Fernandez, JE
- Alvarez, L
- Caba, O
- Aranega, A
CELLULAR AND MOLECULAR BIOLOGY - 06/2003
- JCR Quartile: Q4 (2003)
- SJR Quartile: Q1
- JCR Impact Factor: 1.153 (2022)
- SJR Categories: Medicine (miscellaneous) (Q1)
This author has no conferences.
This author has no patents.
Nanomedicine and Hyperthermia for the Treatment of Gastrointestinal Cancer: A Systematic Review
- Lidia Gago
- Francisco Quiñonero
- Gloria Perazzoli
- Consolacion Melguizo
- Jose Prados
- Raul Ortiz
- Laura Cabeza
Pharmaceutics - 13/06/2023
- Scopus
- ORCID
- Web of Science
Synthesis, solubility and antitumor activity of maslinic acid derivatives
- Fuentes-Rios, D.
- Cepero, A.
- Garcia-Castro, M.
- Contreras-Caceres, R.
- Lopez-Romero, J. M.
- Luque, C.
- Cabeza, L.
- Melguizo, C.
- Prados, J.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY REPORTS - 4/2022
Correction: Specific driving of the suicide E gene by the CEA promoter enhances the effects of paclitaxel in lung cancer (Cancer Gene Therapy, (2019), 10.1038/s41417-019-0137-3)
- Ballesteros A.
- Hernández R.
- Perazzoli G.
- Cabeza L.
- Melguizo C.
- Vélez C.
- Prados J.
CANCER GENE THERAPY - 1/1/2020
- JCR Impact Factor: 5.987 (2020)
- CiteScore: 8.1 (2020)
- SJR: 1.535 (2020
- SNIP: 1.113 (2020
- JCR 5-year Impact Factor: 5.358
- JCR Categories: MEDICINE, RESEARCH & EXPERIMENTAL
Downregulated microRNAs in the colorectal cancer: Diagnostic and therapeutic perspectives
- Hernández R.
- Sánchez-Jiménez E.
- Melguizo C.
- Prados J.
- Rama A.R.
BMB Reports - 1/1/2018
- SJR Quartile: Q1
- JCR Impact Factor: 2.966 (2018)
- CiteScore: 6 (2020)
- SJR: 1.082 (2018
- SNIP: 0.952 (2018
- JCR 5-year Impact Factor: 2.838
- JCR Categories: BIOCHEMISTRY & MOLECULAR BIOLOGY
- SJR Categories: Medicine (miscellaneous) (Q1); Biochemistry (Q2); Molecular Biology (Q2)
- Scopus
- ORCID
- Web of Science
Contact info
Email: melguizo@ual.es
h index
Scopus: 27
Web of Science: 30
i10 index
Scopus: 78
Web of Science: 90
Author profiles
-
ORCID
-
Web of Science ResearcherID
-
Scopus Author ID
-
Dialnet id
Research projects at UAL
-
Acronym CV20-78799Since: September 8, 2020Until: September 7, 2021Funded by: JUNTAFunding / grant amount: 60,000.00 EURRole: Investigador